Sunil Karnawat

Sunil Karnawat serves as the Chief Commercial Officer at Rezolute, Inc., a company focused on treating hypoglycemia due to hyperinsulinism. With extensive experience in market access and commercial operations across multiple organizations, Sunil has held leadership roles at Cytokinetics, Ultragenyx, Myriad Genetics, VIVUS, Novo Nordisk, and Johnson & Johnson. Key accomplishments include developing strategies for product access and reimbursement and leading significant teams in the biopharmaceutical industry. Sunil is also a FoCUS member at MIT, addressing access and reimbursement challenges for gene and cell therapies. Educationally, Sunil holds multiple MBA degrees and a Ph.D. in Engineering, alongside a Bachelor's degree in Civil Engineering.